Harada Yuko, Miyazaki Shinichiro
Internal Medicine, Shin-yurigaoka General Hospital.
Radiation Oncology, Shin-yurigaoka General Hospital.
Cureus. 2017 Feb 26;9(2):e1056. doi: 10.7759/cureus.1056.
The standard treatment for advanced thymic carcinoma has not yet been established. Most patients have no symptoms until the advanced stage. Radiation therapy has been used for advanced stage cancer, usually in combination with surgery or chemotherapy; however, the survival rates are 30%-50%. We performed hypofractionated stereotactic radiotherapy with CyberKnife (Accuray, Sunnyvale, CA, USA) for 10 cases of advanced thymic cancer. All cases reached at least partial remission (PR) in two months with progression-free irradiated lesions and minimal radiation-related toxicity. It took only seven to 12 days for each therapy that did not require admission. CyberKnife is beneficial for patients even at the terminal stage.
晚期胸腺癌的标准治疗方法尚未确立。大多数患者直到晚期才出现症状。放射治疗已用于晚期癌症，通常与手术或化疗联合使用；然而，生存率为30%-50%。我们使用射波刀（美国加利福尼亚州森尼韦尔市Accuray公司生产）对10例晚期胸腺癌患者进行了大分割立体定向放射治疗。所有病例在两个月内均至少达到部分缓解（PR），照射部位无疾病进展，且与放疗相关的毒性极小。每次治疗仅需7至12天，无需住院。即使对于晚期患者，射波刀也是有益的。
